Arformoterol 13D3
| Product Name | Arformoterol 13D3 |
|---|---|
| Alternate Names | Formoterol Stable Isotopes, Stable Isotopes of Formoterol |
| CAT No. | CS-O-15663 |
| CAS No. | 67346-49-0 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Formoterol |
| Therapeutic | Anti-Asthma / COPD |
| Smileys | O[C@H](C1=CC(NC=O)=C(O)C=C1)CN[C@H](C)CC2=CC=C(O[13C]([2H])([2H])[2H])C=C2 |
| Canonical Smiles | CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O |
| InchIKey | BPZSYCZIITTYBL-YJYMSZOUSA-N |
| Inchl | InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1 |
| IUPAC | N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Arformoterol 13D3 is a synthetic compound that is used as a bronchodilator in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It is a long-acting beta-2 agonist that works by relaxing the smooth muscles in the airways, making it easier to breathe. Arformoterol 13D3 is typically administered via inhalation, either through a nebulizer or a metered-dose inhaler, and can provide relief for up to 12 hours.
Chemically, Arformoterol 13D3 is a derivative of formoterol, which is a selective beta-2 adrenergic agonist. It is labeled as 13D3 to indicate that it is a deuterated version of the original compound, meaning that some of the hydrogen atoms in the molecule have been replaced with deuterium atoms. This modification is intended to improve the pharmacokinetic properties of the drug, such as its bioavailability and half-life, and may also reduce the risk of side effects.
Arformoterol 13D3 has been extensively studied in clinical trials and has been shown to be an effective treatment for COPD and asthma. It is typically used in combination with other medications, such as inhaled corticosteroids, to manage symptoms and improve lung function. As with any medication, Arformoterol 13D3 should only be used under the guidance of a healthcare professional and patients should be monitored for any adverse effects.
Get an Instant Quote
Related Compounds
Arformoterol tartrate D6 | N-Methyl Formoterol-d3 Fumarate (Mixture of Diastereomers) | Formoterol D6 | Formoterol d6 Tartarate | Arformoterol D3 | Formoterol D6 fumarate | N-Deformyl Formoterol-d6 Fumarate (Mixture of Diastereomers) | Rac Formoterol D6 |